Insider · CIK 0001276750
David Kirske
cfoofficer
Files at XFOR (X4 Pharmaceuticals, Inc). First filing Oct 5, 2026, latest Oct 5, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $34k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
XFOR: X4 Pharmaceuticals, Inc
XFOROct 9, 2026 · close 2.91
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 28Weak | XFORsell X4 Pharmaceuticals, Inc | $34k 11,767 shares | -7% | 0% from low-39% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | XFOR X4 Pharmaceuticals, Inc | SOpen-market sale Common Stock | -11,767 | $2.86 | $34k | 155,983 | 7 d ago |
| Oct 29, 2025 | XFOR X4 Pharmaceuticals, Inc | AGrant or award Stock Option (right to buy)derivative | +1,552,769 | $0.00 | $0 | 1,552,769 | Oct 31, 2025 |
| Aug 14, 2025 | XFOR X4 Pharmaceuticals, Inc | AGrant or award Common Stock | +193,254 | $0.00 | $0 | 193,254 | Aug 14, 2025 |
| Aug 12, 2025 | XFOR X4 Pharmaceuticals, Inc | AGrant or award Stock Option (right to buy)derivative | +1,073,249 | $0.00 | $0 | 1,073,249 | Aug 14, 2025 |
| Aug 14, 2025 | XFOR X4 Pharmaceuticals, Inc | AGrant or award Stock Option (right to buy)derivative | +352,800 | $0.00 | $0 | 352,800 | Aug 14, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.